Form 4 for MRNA Moderna
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0000950170-23-004437 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-24 | 2023-02-22 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $160.35 | -10.0K | 2.20M | -0.5% | -$1.60M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-22 | S | D | 10,000 | $160.35 | 2,197,209 | D | — | — |